Time period | IRR (95% CI) of cancer type | ||||
---|---|---|---|---|---|
Bladder | Breast | Colorectal | Kidney | Non-Hodgkin lymphoma | |
SOE | 0.87 (0.72–1.03) | 0.67 (0.59–0.76) | 0.64 (0.56–0.74) | 0.92 (0.72–1.16) | 0.98 (0.81–1.18) |
PostSOE | 1.01 (0.97–1.05) | 1.10 (1.06–1.13) | 1.08 (1.04–1.12) | 1.00 (0.94–1.06) | 0.96 (0.92–1.00) |
Lung | Melanoma | Prostate | Uterine | Cervical | |
SOE | 0.93 (0.83–1.04) | 0.57 (0.47–0.69) | 0.64 (0.56–0.73) | 0.86 (0.70–1.06) | 1.14 (0.75–1.75) |
PostSOE | 1.02 (0.99–1.05) | 1.09 (1.05–1.14) | 1.08 (1.05–1.12) | 1.04 (0.99–1.09) | 0.97 (0.87–1.07) |
Note: CI = confidence interval, IRR = incidence rate ratio, PostSOE = estimated as the exponent of β4, SOE = state of emergency, estimated as the exponent of β3.